Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Human insulin via microinfusion may effectively improve atrophic acne scars.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

A new hair loss treatment with two unique ingredients improved hair growth.

Epimorphin helps start hair growth in mice.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to weight loss-related nutrient deficiency.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Methylene blue, combined with ceramides, may reduce skin and hair side effects from GLP-1 therapy.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

Biomimetic peptides improved hair growth and increased growth factors in hair follicles for hair loss patients.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

A peptide called DPS-1 helps human scalp cells grow and stimulates hair growth in mice.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.